A Phase 1 Study of ASP3082 in Participants with Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies with KRAS G12D Mutation
Phase I
Phase I
Phase I
I
Berlin, Jordan
NCT05382559
VICCPHI2207
